Patient treatment preferences for osteoporosis
Fraenkel L, Gulanski B, Wittink D. Patient treatment preferences for osteoporosis. Arthritis & Rheumatism 2006, 55: 729-735. PMID: 17013870, PMCID: PMC1626097, DOI: 10.1002/art.22229.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAgedAged, 80 and overBone Density Conservation AgentsCross-Sectional StudiesDiphosphonatesDose-Response Relationship, DrugFemaleFractures, BoneHealth Care SurveysHumansInfusions, IntravenousInjections, SubcutaneousMaleMiddle AgedOsteoporosisParathyroid HormonePatient CompliancePatient SatisfactionRecombinant ProteinsRisk AssessmentSurveys and QuestionnairesConceptsPreferred treatment optionRoute of administrationPatient's preferred treatment optionRecombinant human parathyroid hormoneOsteoporosis treatment optionsTreatment optionsAnnual infusionPatient preferencesTreatment preferencesIntravenous bisphosphonatesTreatment choiceRisk of vertebralTreatment-naive participantsPatients' treatment preferencesLong-term adherenceIndividual patient preferencesHuman parathyroid hormoneOral bisphosphonatesOsteoporosis medicationsWeekly bisphosphonatesWeekly pillConjoint analysis questionnaireOral medicationsHip fractureFuture fractures